ESC 365 - Plasma proteomics identify fibroblast growth factor 5 as a biomarker for genetically proven Familial Hypercholesterolemia

ESC Professional Premium Access

Plasma proteomics identify fibroblast growth factor 5 as a biomarker for genetically proven Familial Hypercholesterolemia

Session: Cardiovascular risk assessment: biomarkers

Topic: Biomarkers

Speaker: Doctor A. Baragetti (Milan, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Andrea Baragetti

University of Milan, Milan (Italy)

0 follower

3 more presentations in this session

The association of lipoprotein(a) with patient characteristics and mortality in a primary prevention cohort: data from our clinic database

Speaker: Doctor L. Cho (Cleveland, US)

Plasma levels of amyloid beta 1-40 are associated with ultrasonographic morphological characteristics related with carotid plaque vulnerability in individuals without cardiovascular disease

Speaker: Doctor D. Delialis (Athens, GR)

Association of random glucose to albumin ratio with post-contrast acute kidney injury and clinical outcomes in patients with ST-elevation myocardial infarction

Speaker: Mr Y. Liu (Guangzhou, CN)

Access the full session

Cardiovascular risk assessment: biomarkers

Speakers: Doctor A. Baragetti, Doctor L. Cho, Doctor D. Delialis, Mr Y. Liu

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources